Search page

Beyond the intravenous route for drug desensitization to chemotherapeutic agents and monoclonal antibodies: Intramuscular, subcutaneous, and intraperitoneal protocols

Biomarker-driven drug development for allergic diseases

Blame the drug or the additive?

Breaking the Reaction Cycle: Tailored Solutions for Contrast Media Hypersensitivity

Can piperacillin-tazobactam be a safe alternative in patients with hypersensitivity to amoxicillin?

Carbamazepine induced Drug reaction with eosinophilia and systemic symptoms (DRESS) with cross-reactivity to lamotrigine confirmed by a positive rechallenge

Cephalosporine drug provocation in a population of children with confirmed serum sickness-like reaction to amoxicillin

Challenging decisions: Feasibility and safety of multiple low-risk drug challenges in a single clinic visit during peri-operative anaphylaxis investigation

Characterization patient’s cohort with drug reaction with eosinophilia and systemic symptoms during the years 2022 and 2023 at University of Chile Clinical Hospital

Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs

Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs

Clinical Features of Pediatric Cases Followed with the Diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Single-Center Experience

Clinical Pathway on direct drug provocation testing

Clinical and Epidemiological insights into generalized bullous fixed drug eruption (GBFDE) in African TB HIV endemic settings: A comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)

Clinical history seen with different hypersensitivity reactions

Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study

Controversies in Drug Provocation Tests

Corticosteroids hypersensitivity – a decade review

Covid 19 vaccines induced acute urticaria: benign or serious hypersensitivity manifestation to vaccines?

Delayed Hypersensitivity Reaction to Clavulanic Acid: A Case Report

Delayed hypersensitivity reactions to non steroidal anti-inflammatory drugs : a cases study

Delayed-Type Hypersensitivity to Omalizumab

Descriptive bias in the clinical history of adverse drug reactions in children

Desensitization Decoded: Personalized pediatric drug allergy management

Desensitization Protocol for Cemiplimab Immediate Hypersensitivity Reactions due to Cytokine Release in Lung Cancer: Report of 2 cases

Desensitization to ampicillin fixed drug eruption. Spotting the solution to fix the heart

Diagnosis of Hypersensitivity to Exogenous Progestogens and the Actual Utility of Allergological Tests. A Case Study

Differential diagnosis of Drug allergy

Digging Deeper the Significance of Mast Cell Tryptase Elevation in Perioperative Immediate Hypersensitivity

Direct drug provocation test with beta-lactams in children and adolescents

Drug Allergy

Drug Allergy: Advances in Diagnosis, Management, and Prevention

Drug Allergy: Implementing the Latest EAACI Guidelines in Clinical Practice

Drug Allergy: Today and Tomorrow

Drug Allergy: from bench to bedside

Drug Induced Anaphylaxis Maybe The Only Manifestation of Systemic Mastocytosis

Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles

Drug allergy

Drug allergy – Session 1: Diagnosis

Drug allergy during childhood

Drug allergy severity and quality of life: Data from the BIOGRIAL study

Drug desensitization in pediatric patients – A challenging, effective and safe approach

Drug provocation test to acetyl salicylic acid in a children cohort

Drug provocation tests with beta-lactam – from suspicion to confirmation

Drug provocation tests: which protocol to follow?

Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by bortezomib and trimethoprim/sulfamethoxazole

Drug reaction with eosinophilia and systemic symptoms (DRESS) concomitant to SARS cov2 infection induced by sulfasalazine with a relapse to mesalasine

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a Romanian University Hospital

Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity

Drug – induced anaphylaxis in childhood

Drug-induced bullous drug eruptions: a case series

Dual intracellular staining of CD154(CD40L) and cytokines at single cell level: a novel aid to document immediate hypersensitivity to rocuronium

Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report

Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge

Efficacy and Safety of Chemotherapeutic Drug Desensitization in Children

Endotype based classification of NSAID hypersensitivity in children

Epidemiology and clinical management of drug allergy

Evaluating NSAIDs hypersensitivity in patients chronic rhinosinusitis

Evaluation of Awareness Regarding Drug Allergy and Rational Use Of Medicines Among Parents of Hospitalized Pediatric Patients

Evaluation of MRGPRX2-mediated mast cell activation in immediate hypersensitivity reactions to neuromuscular blocking agents

Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease

Expanding the Differential Diagnosis of Blood-culture-negative Endocarditis: A Case Report of Delayed-type Hypersensitivity to Bioprosthetic Valve

Features of Perioperative Hypersensitivity Reactions Manifestations in Children with Bronchial Asthma

Ferric Carboxymaltose Hypersensitivity Reactions

First diagnostic confirmation through Lymphocyte Transformation Test of steroid-mediated type IV hypersensitivity

First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting

Fixed Drug Eruption and Its Rare Variants as Food-Related and Generalized Bullous Lesions; A Tale of Three Cases

Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool

Fixed Drug Eruption related to the use of NSAIDs

Fixed Drug Eruption to aminopenicillins: a case series

Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib

Fixed drug eruption caused by lansoprazole

Fixed drug eruption due to Levofloxacin

Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study

Flash talks on Drug Allergy 1

Flash talks on Drug Allergy 2

Food dependent NSAID-induced hypersensitivity – is there a link to specific components?

Food hypersensitivity reactions in adults: A longitudinal cohort study

Four-Year Analysis of the Incidence and Clinical Features of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit, Universitary Hospital Cruz Roja

From Risk to Solution: Effective Desensitization in a Confirmed Delayed Hypersensitivity Reaction to Albendazole

Glutathione peroxidase single nucleotide polymorphisms associated with nonsteroidal anti-inflammatory drug hypersensitivity-induced urticaria/angioedema

Graded oral challenge to delabel suspected non-steroidal anti-inflammatory drugs (NSAIDs) hypersensitivity in children

How Useful Are Major and Minor Determinants of Penicillin in Evaluating Non-Immediate Hypersensitivity Reactions?

How and when to perform skin tests for possible drug allergy

How to reintroduce drugs in cutaneous adverse drug reactions

Hyaluronidase hypersensitivity mimicking orbital cellulitis

Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital

Hypersensitivity Reactions to Iodinated Contrast Media: Insights from a Retrospective Cohort

Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity

Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?

Hypersensitivity reactions in biologicals

Hypersensitivity reactions to Proton pump inhibitors: Patterns of cross- reactivity in a Tunisian series

Hypersensitivity reactions to platinum salts and taxanes: determination of mediator release and relation with endotypes involved and reaction severity

Hypersensitivity reactions to xanthine oxidase inhibitors: Facts or myths ?

Hypersensitivity to Biologicals

Hypersensitivity to Bismuth subcitrate

Hypersensitivity to Corticosteroids

Hypersensitivity to Local anaesthetic drugs

Hypersensitivity to Proton Pump Inhibitors: Are Agents Determined by Provocation Tests in the Clinic Safe in Real Life?

Hypersensitivity to allopurinol: would desensitization be an effective procedure?

Hypersensitivity to antihistamines

Hypersensitivity to biologicals

Hypersensitivity to drugs used to treat allergy

Hypersensitivity to quinolones: the daily life in our hospital

Hypersensitivity to rocuronium: resolving the IgE – MRGPRX2 conundrum.

Hypersensitivity to sulfonamides

Hypersensitivity to vancomycin and quinolones

Identifying the most at-risk age-group and longitudinal trends of drug allergy labelling among 7.3 million individuals in Hong Kong

Immediate Hypersensitivity Reactions to Proton Pump Inhibitors – diagnostic workup

Immediate Hypersensitivity to Chlorhexidine: A Case Series

Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity

Immediate hypersensitivity to Pristinamycin

Immediate hypersensitivity to non-steroidal anti-inflammatory drugs: a retrospective analytic descriptive study

Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Impact of the drug allergy challenges’ outcome on children and parents

Impact of variants in genes related to acetaminophen biodisposition on the risk of developing selective acetaminophen hypersensitivity

Improving NMBA hypersensitivity management using CD203c activation marker in basophil activation tests

Incidence of Perioperative Hypersensitivity Reactions in Spanish Hospital Cohorts – A Two-Year investigation (2022-2023)

Incidence of Perioperative Hypersensitivity Reactions in Spanish hospitals group. Three years of study 2022 to 2024

Incidence of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit of Hospital Central Cruz Roja. Tree-year study

Increased incidence of suspected clindamycin hypersensitivity reactions in pediatric patients due to its expanded use in clinical practice

Innovation Hub 5 – Application of Artificial Intelligence in drug discovery: the bigger picture

Innovation in drug allergy education: partnerships and potential across the Asia Pacific and beyond

Insights from Drug Provocation Testing in Quinolone Allergy

Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?

Iodinated contrast media-induced delayed hypersensitivity with multisensitization

Is an Early-Type Hypersensitivity Reaction Possible with Both Peroral and Parenteral Anticoagulant Drugs? A Successful 2-Day Peroral Desensitization Protocol to Rivaroxaban

Isolated Basophils Maintain Functionality and Specificity: A Promising Prospect for Future Drug Allergy Studies

Knowledge, Attitude, and Practice of Pediatric Drug Allergy among Medical Interns: A Cross-Sectional Study

Long-term outcomes of drug reaction with eosinophilia and systemic symptoms: a ten-year prospective study from a tertiary center

Lymphocyte transformation test in the diagnosis of DRESS Syndrome: What criteria are most effective in determining drug causality?

Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents

Management of hypersensitivity to chemotherapy

Mastocytosis or Drug hypersensitivity? (Clinincal case)

Mechanisms and management of hypersensitivity induced by specific drugs

Mechanisms of drug desensitization

Meloxicam as a Safe Bet: Rethinking the Approach to NSAID Hypersensitivity Alternative Drugs

Misdiagnosed Drug Hypersensitivity: A 15-Year Investigation into the Rare Occurrence of True Lidocaine Allergies

Multidisciplinary approach in drug allergy

Multiple Fixed Drug Eruption with Arylpropionics and Nolotil: A Case Report

NSAID hypersensitivity phenotypes

Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings

Non – immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity Reactions: An approach to assessment, diagnosis, and management in a paediatric population

Non-immediate hypersensitivity reaction to different insulins: A case report

Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels

Novel Approaches for Drug Allergy

Novel analytical tool supporting drug development and biomarker discovery: The era of machine learning in Allergy and Immunology

OAS2 – Drug and Skin Allergy

Optimising Amoxicillin Hypersensitivity Assessment: A Prospective Study Investigating the Synergistic Impact of Amoxicillin and Lipopolysaccharide in Basophil Activation Testing

Our experience with rapid desensitisation in delayed hypersensitivity reactions to biological drugs

PDS12: Drug Allergy

Paediatric case of Drug Induced Enterocolitis Syndrome (DIES) due to amoxicillin

Paracetamol-induced fixed drug eruption: A case Series

Pediatric drug desensitizations: National experience

Perioperative Hypersensitivity Reactions in a Spanish Hospital Group

Perioperative Immediate Hypersensitivity Reactions: First Chilean Cohort Study 2020-2024 Clinical Hospital University of Chile

Pharmacogenetics of drug allergy

Pharmacogenetics of hypersensitivity syndrome induced by carbamazepine

Pharmacogenomics and Precision Medicine in Drug Allergy: From Research to Clinical Application

Placebo and nocebo responses in drug allergy

Positive HLA-B*13:01 Allele in a Patient with Clinical Diagnosis of Drug Induced Eosinophilia with Systemic Symptoms (DRESS)

Practical approaches to the diagnosis of hypersensitivity to Nonsteroidal Anti-inflammatory drugs

Practical management of cutaneous adverse drug reactions

Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs

Quinolone Hypersensitivity Investigation in a Clinical Setting

Rapid drug desensitization in children: case report

Rapid drug desensitization to taxanes: a descriptive study from Turkey

Re-introduction of drugs in drug reaction with eosinophilia and systemic symptoms

Recognizing and Managing Severe Cutaneous Adverse Drug Reactions

Reflection on the Role of Basophil Activation Test in the Diagnosis of Pediatric Drug Allergy

Related factors to cefazolin perioperative hypersensitivity reactions

Relevance of Administration Route in Immediate Hypersensitivity Reactions to Fluoroquinolones

Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics

Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs

Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation

Risk evaluation in hypersensitivity to chemotherapy

Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

Safe Strategy for NSAID Reintroduction in moderate to severe asthmatics with COX-1 NSAID hypersensitivity

Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Safety of Single-Dose Drug Provocation Test in Low Risk Non-Immediate Reactions with Beta-Lactam Antibiotics in Children

Safety of a Three-Step Provocation Test in Mild Hypersensitivity Reactions to Beta-Lactams

Safety of direct and single-dose drug provocation test in low-risk penicillin allergy labels

Shedding Light on the Controversy: Are Drug Challenges with Iodinated Contrast Media Useful?

Should we perform prolonged drug provocation routinely?

Simultaneous double drug provocation test in a low risk patient to refute unlikely allergy to paracetamol and ibuprofen

Successful Case Series of Desensitization Shortening for Chemotherapy-Induced Hypersensitivity

Successful Desensitisation for Delayed Cutaneous Kaftrio Hypersensitivity

Successful Desensitization with CFTR Modulatory Drugs in Delayed Cutaneous Hypersensitivity Reactions

Successful Prevention of Subsequent L-Asparaginase Hypersensitivity in Children through Premedication: A Single-Center Experience

Successful Rapid Desensitization in a Patient with Metastatic Colorectal Cancer Presenting with Regorafenib-Mediated Fixed Drug Eruption

Successful Rapid Desensitization with Atezolizumab after severe hypersensitivity reation in a patient with small-cell lung metastatic cancer: a case report

Successful desensitization to nilotinib after imatinib-induced Sweet’s syndrome and nilotinib hypersensitivity reaction in a patient with chronic myeloid leukemia

Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions

Symmetrical drug-related intertriginous and flexural exanthema related to symptomatic slow-acting drug for osteoarthritis (SYSADOA) – a case report

Ten-year Survival in Children with Acute Lymphoblastic Leukemia: The Impact of L-asparaginase Hypersensitivity and Desensitization

The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia

The challenge of drug allergy: A revised nomenclature for allergic diseases is required

The clinical case scenarios for management of drug allergy: to provoke, treat through, or desensitize

The importance of allergological workup in diagnosis of hypersensitivity to local anaesthetics

The most effective plan for my drug allergic patient

The use of risk assessment in drug allergy

The value of skin testing with TNF-inhibitors in patients with local and systemic hypersensitivity reactions

Therapeutic drug monitoring of 6-thioguanine nucleotides

Tranexamic acid as a cause of perioperative hypersensitivity reaction

Trimethoprim-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with reactivation of human herpesvirus-7 (HHV-7)

Two Cases of Multiple Drug Hypersensitivity: Diagnosis and Clinical Management

Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity

Unlocking the Potential of Cytokines for Endotyping Immediate Hypersensitivity Reactions Induced by Chemotherapeutic and Biological Agents

Unveiling the Impact of NSAIDs Hypersensitivity Reactions: A Tertiary Hospital Perspective

Use of dendrimeric nanostructures in mast cell activation test for evaluating IgE-mediated hypersensitivity to amoxicillin

Using an Environmental Exposure Chamber (EEC) to Conduct Allergy Trials Mitigates Trial Disruptions and Provides Consistent Drug Testing Outcomes after the Trial is Resumed

Value of a specialised series of patch tests in a cohort of patients referred for hypersensitivity to their orthopaedic implant: a multicentre study by the Groupe de dermato-allergologie (DAG) of the Société Française de Dermatologie (SFD)

Visiting the emergency room with a drug allergy label. Our experience in real life

Vitamin D3 deficiency disturbed immune response and respiratory function in the murine model of hypersensitivity pneumonitis

Vitamin D3 deficiency promotes epithelial-to-mesenchymal transition and thus favours pulmonary fibrosis development in the murine model of hypersensitivity pneumonitis

What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience

When Immunotherapy Strikes Twice: IgE Hypersensitivity and HES as Dual Adverse Effects of Pembrolizumab

When and how can a drug provocation test be indicated in severe cutaneous adverse reactions?

Which skin tests can be used for delayed cutaneous adverse drug reactions?

A case report of multiple drug hypersensitivity triggered by DRESS to beta-lactamase inhibitors

A rare case of IgE-mediated multiple drug hypersensitivity syndrome

Adverse drug reactions to taxanes: positive skin testing correlates with breakthrough reactions during drug desensitisation

Assessing Hypersensitivity to Iodinated Contrast Media: Insights from Skin Testing and Drug Challenges

Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity

Current understanding of nonsteroidal anti-inflammatory drug hypersensitivity

Delayed drug hypersensitivity to bortezomib: an effective desensitization

Delayed-Type Drug Allergy Combined with Adverse Drug Reactions

Drug Hypersensitivity Reactions In A Pediatric Population Before And After COVID-19 Pandemic – A Retrospective Study In A Portuguese Hospital Center

Drug allergy – Session 2: Precision medicine in drug allergy

Drug provocation using two equal doses in patients with suspected drug allergy

EAACI position paper about basophil activation test in immediate drug hypersensitivity

Evaluation of fixed drug eruption – skin test or drug provocation test?

Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”

Frequency of Long-Term Development of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity in Patients who Underwent Nasal Polypectomy during Childhood

Generalised fixed drug eruption induced by propofol: A rare case of delayed type IV hypersensitivity reaction

Hypersensitivity to endogenous progesterone manifested as fixed drug eruption: a case report

Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age

Is premedication useful to prevent non-IgE mediated immediate drug hypersensitivity reactions

Management of delayed drug hypersensitivity reactions

Mastocytosis and drug hypersensitivity

Multidisciplinary approach in the management of hypersensitivity reactions to biological agents and successful rapid drug desensitization

Pediatric Drug Hypersensitivity

Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation

Platinum drug hypersensitivity reactions – diagnosis and management with desensitization

Riddles of drug hypersensitivity diagnosis: a case series

The difficult scenarios in drug hypersensitivity in children

The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics

Variability in the genes involved in the cellular redox status, and their association with drug hypersensitivity reactions to nonsteroidal anti-inflammatory drugs and ß-lactam antibiotics

Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website